Protein Expression of Fas, Fas Ligand, Bcl-2 and TGFβ2 and Correlation with Survival in Initial and Recurrent Human Gliomas

By Strege Rainer   Godt Christian   Stark Andreas   Hugo Heinz-Hermann   Maximilian Mehdorn H.  

Journal of Neuro-Oncology, Vol. 67, Iss. 1-2, 2004-03 ,pp. : 29-39

Springer Publishing Company

Access to resources Recommend Favorite

Activation of Fas Ligand/Receptor System Kills Ovarian Cancer Cell Lines by an Apoptotic Mechanism

By Ghahremani M.   Foghi A.   Dorrington J.H.  

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 275-281

Elsevier

Access to resources Recommend Favorite

Fas ligand expression in BRCA1-associated hereditary breast carcinoma clearly differs from that in sporadic breast carcinoma

By Ito Y.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 2, 2001-03 ,pp. : 95-100

Springer Publishing Company

Access to resources Recommend Favorite

Okadaic acid stimulates expression of Fas receptor and Fas ligand by activation of nuclear factor kappa-B in human oral squamous carcinoma cells

By Fujita M.   Goto K.   Yoshida K.   Okamura H.   Morimoto H.   Kito S.   Fukuda J.   Haneji T.  

Oral Oncology, Vol. 40, Iss. 2, 2004-02 ,pp. : 199-206

Elsevier

Access to resources Recommend Favorite

Soluble Fas and Fas-ligand in bladder cancer in vitro and in vivo

By Perabo F.G.E.   Mattes R.H.   Wirger A.   Steiner G.   Kamp S.   Schmidt D.   Pegelow K.   von Ruecker A.   Muller S.C.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 4, 2001-07 ,pp. : 163-169

Elsevier

Access to resources Recommend Favorite